IasconeC., BarrecaM.Carcinosarcoma and pseudosarcoma of the esophagus: two names, one disease—comprehensive review of the literature.World J Surg1999; 23: 153–7.
2.
OsamuraR.Y., ShimamuraK., HataJ.Polypoid carcinoma of the esophagus.Am J Surg Pathol1978; 2: 201–8.
3.
McCortJ.Esophageal carcinosarcoma and pseudosarcoma.Diagnostic Radiology1972; 102: 519–24.
4.
IyomasaS., KatoH., TachimoriY.Carcinosarcoma of the esophagus: a twenty-case study.Japan Journal of Oncology1990; 20: 99–106.
GabskiV., BurmeisterB., SmithersB.M.Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta analysis.Lancet Oncol2007; 8: 226–34.
7.
Al-SarrafM., MartzK., HerskovicA.Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study.J Clin Oncol1997; 15: 277–84.
8.
UrbaS.G., OrringerM.B., TurrisiA.Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma.J Clin Oncol2001; 19: 305–13.
9.
BossetJ., GignouxM., TribouletJ.Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.N Engl J Med1997; 337: 161–7.
10.
WalshT., NoonanN., HollywoodD.A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.N Engl J Med1996; 335: 462–7.
11.
BurmeisterB., SmithersB., GebskiV.Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomized controlled phase III trial.Lancet2005; 6: 659–68.
12.
UrschelJ., VasanH.A met-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.Am J Surg2003; 185: 538–43.
13.
TepperJ., KrasnaM.J., NiedzwieckiD.Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.J Clin Oncol2008; 26: 1086–92.
14.
StahlM., StuschkeM., LehmannN.Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.J Clin Oncol2005; 23: 2310–7.
15.
BedenneL., MichelP., BouchéO.Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.J Clin Oncol2007; 25: 1155–6.
16.
FletcherJ.W., DjulbegovicB., SoaresH.P.Recommendations on the use of 18FDG PET in oncology.J Nucl Med2008; 29: 480–508.
17.
KrauseB., HerrmannK., WiederH., Meyer zum BüschenfeldeC.18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer.J Nucl Med2009; 50: 89S–96S.
18.
SwisherS.G., MaishM., ErasmusJ.J.Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.Ann Thorac Surg2004; 78: 1152–60.
